Untreated pathogens sits at the center of this dementia and brain health question.

Untreated pathogens accelerate brain function decline by triggering a cascade of inflammatory and degenerative processes within the brain itself. Research involving nearly 1 million people found that the risk of dementia increased by 50% over a median follow-up period of roughly 5 years after contracting various common infections.

What makes this finding particularly significant is the timeline: dementia-related infections typically occurred 5 to 6 years before formal dementia diagnosis, suggesting that pathogens quietly accelerate the underlying cognitive decline that eventually becomes recognizable as disease. A person might dismiss a respiratory infection or get treated for a urinary tract infection without realizing that the pathogen has already begun damaging brain tissue and triggering immune responses that will compound over years. This article explores which pathogens pose the greatest threat, the biological mechanisms by which they harm the brain, and how treatment and prevention can reduce this risk.

How Common Infections Increase Dementia Risk
Which Pathogens Damage the Brain?
The Biological Mechanisms Behind Infection-Driven Brain Damage
Why the Cumulative Burden of Multiple Infections Matters Most
Long-COVID and Accelerated Brain Aging
The Emerging Role of the Gut Virome in Brain Aging
Vaccination as a Brain-Protective Strategy
Conclusion

How Common Infections Increase Dementia Risk

The connection between infection and dementia is not theoretical. Johns Hopkins Bloomberg School of Public Health researchers examined middle-aged and older adults and found that signs of common infections were associated with poorer cognitive performance on standardized tests. More striking still: when researchers counted positive antibody tests from five different infections, they found a clear pattern—the greater the number of past infections, the poorer the cognitive performance. This is not about a single catastrophic infection; it is about the cumulative burden of infections over a lifetime.

A person who has had herpes simplex virus, cytomegalovirus, and Chlamydia pneumoniae is at greater risk than someone with exposure to just one of these pathogens. The timeframe is another critical detail often overlooked in discussions of dementia prevention. Because infections can damage the brain years before symptoms emerge, many people with undiagnosed mild cognitive impairment or early-stage dementia may attribute their memory problems to normal aging rather than to past infections. A woman in her 60s might forget where she left her keys or struggle to recall a colleague’s name, not realizing that a respiratory infection from a decade earlier set the neurological stage for her current decline. This lag between infection and diagnosis makes prevention and early treatment of infections especially important during middle age, when the brain remains plastic enough to resist some damage but still vulnerable to accumulated injury.

How Common Infections Increase Dementia Risk

Which Pathogens Damage the Brain?

A growing body of research has identified specific pathogens that accumulate in the brain or trigger neuroinflammatory responses linked to dementia. Among viruses, herpes simplex virus 1 (HSV-1) has received particular attention; some studies suggest it reactivates in the brain and contributes to amyloid-beta accumulation. Epstein-Barr virus (EBV), which causes infectious mononucleosis, can persist in neural cells. Cytomegalovirus (CMV), influenza, and increasingly, SARS-CoV-2, have all been implicated in cognitive decline. Bacteria present another threat: Chlamydia pneumoniae can cross the blood-brain barrier, while Helicobacter pylori has been associated with neuroinflammation. Porphyromonas gingivalis, a bacterium involved in periodontal disease, may reach the brain through the bloodstream or through retrograde transport along nerve fibers.

Spirochetes, a group of spiral-shaped bacteria, have been detected in the brains of Alzheimer’s patients. Even parasites like Toxoplasma gondii, often acquired from cat litter or undercooked meat, may contribute to neurological harm. The challenge for medical practice is that many of these infections cause minimal acute symptoms, allowing them to persist undetected or undertreated. A person might have chronic periodontal disease—characterized by low-grade bacterial infection in the gums—without ever connecting it to their brain health. Similarly, many people carry latent herpesviruses that reactivate intermittently without producing obvious illness. The body’s immune response to these chronic infections, even when the infection itself is sub-clinical, appears sufficient to damage delicate neural tissue over years.

The Biological Mechanisms Behind Infection-Driven Brain Damage

When a pathogen enters the brain or when the immune system responds to infection elsewhere in the body, several mechanisms of neuronal damage unfold simultaneously. The brain contains specialized immune cells called microglia that normally maintain the brain environment and clear debris. In response to infection, microglia become hyperactivated, producing inflammatory molecules that can damage neighboring neurons. Concurrently, pathogens or the immune response against them may trigger aggregation of amyloid-beta (Aβ) protein and hyperphosphorylation of tau protein—two hallmark pathologies of Alzheimer’s disease. Some evidence suggests that microbial proteins can directly seed amyloid-beta aggregation, essentially instructing brain cells to produce more of the toxic plaques associated with dementia.

Chronic neuroinflammation becomes self-perpetuating. The initial immune activation produces cytokines and other inflammatory molecules that kill neurons and damage synapses. This neuronal death and disruption trigger further immune activation, establishing a vicious cycle. Additionally, infections may disrupt the blood-brain barrier, the specialized lining that normally prevents pathogens and large molecules from entering the brain. Once the barrier is compromised, more pathogens can gain access, and systemic inflammation from the body can cross into the brain more easily, amplifying neurological damage. A person recovering from a severe respiratory infection might have temporarily compromised blood-brain barrier function—a window during which the brain is especially vulnerable to additional injury.

The Biological Mechanisms Behind Infection-Driven Brain Damage

Why the Cumulative Burden of Multiple Infections Matters Most

The research is clear on one point: the cumulative burden of multiple infections over time appears more significant than the risk posed by a single pathogen. A person with one episode of a herpes infection faces some risk; a person with herpes, past cytomegalovirus infection, and chronic periodontal disease faces a compounding risk that exceeds the sum of the individual threats. This insight has important implications for how we think about infection prevention and brain health.

It is not enough to treat one infection and assume the brain is protected; rather, every infection prevented throughout life contributes to preserving cognitive reserve and reducing dementia risk. This cumulative model also explains why some individuals develop cognitive decline while others do not, even in the presence of similar genetic risks for Alzheimer’s disease. Two people with identical APOE4 genotype (a known Alzheimer’s risk gene) may have very different cognitive trajectories depending on how many infections they have accumulated and how aggressively those infections were treated. A person who had chickenpox as a child, received a zoster vaccine in their 60s, treats urinary tract infections promptly with antibiotics, and maintains oral hygiene to prevent periodontal disease faces much lower cumulative pathogen burden than someone with multiple untreated or undertreated infections over the same span.

Long-COVID and Accelerated Brain Aging

Since 2020, emerging evidence has shown that SARS-CoV-2, the virus causing COVID-19, has particularly severe effects on the brain. Even in individuals who recover from acute COVID-19, the virus or its inflammatory aftermath can cause lasting cognitive dysfunction. Neuroimaging studies show that SARS-CoV-2 causes hippocampal damage—the hippocampus being critical for memory formation—and triggers activation of astrocytes and microglia, the brain’s immune cells. The virus induces a cytokine-mediated neurotoxic response, essentially poisoning brain tissue through inflammatory signaling. Patients recovering from COVID-19 report cognitive and affective disturbances including fatigue, apathy, low mood, and executive dysfunction—the very functions that decline in early dementia.

Long-COVID demonstrates that the threat from infection extends beyond the acute phase of illness. A person who had severe COVID-19 months or even years ago may still be experiencing brain-based symptoms that persist because the neuroinflammatory cascade has not fully resolved. This is not simply “brain fog” that resolves with rest; in some cases, neuropsychological testing shows measurable deficits in attention, processing speed, and memory. Given the prevalence of SARS-CoV-2 infection globally, the long-term cognitive impact on populations—especially in those with prior vulnerabilities—remains an important public health concern. Individuals with long-COVID symptoms should work with healthcare providers to monitor cognitive function and consider preventive strategies to reduce additional infection burden.

The Emerging Role of the Gut Virome in Brain Aging

Recent research has uncovered a surprising link between organisms in the gut and brain health. Alterations in the gut virome—the collection of viruses inhabiting the intestinal tract—appear to contribute to brain aging, cognitive decline, and neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The gut virome influences the composition of the gut microbiome (bacteria), which in turn affects intestinal barrier function and the production of metabolites that reach the brain via the bloodstream. When the virome is altered by infection, antibiotic use, or other disruptions, the downstream effects on brain health can be substantial.

This pathway helps explain how an intestinal infection from years past might influence cognitive decline decades later through shifts in microbial communities that persist long after the acute infection resolves. The practical implication is that brain health is not just about preventing respiratory or systemic infections—gastrointestinal health matters too. Maintaining a balanced gut microbiome through diet, judicious antibiotic use, and prompt treatment of infections appears to be part of preserving cognitive function over the lifespan. Someone with recurrent gastrointestinal infections or who has required multiple rounds of antibiotics should be particularly attentive to other strategies for reducing infection burden and supporting brain health.

Vaccination as a Brain-Protective Strategy

Prevention is far more effective than trying to reverse cognitive decline once it has begun, and vaccination offers a powerful tool for reducing infection-related dementia risk. Research has shown that vaccinated individuals aged 65 and older who received specific vaccines showed a 20-30% decreased risk of developing Alzheimer’s disease over 7-8 years of follow-up. The zoster vaccine (shingles vaccine), which prevents reactivation of varicella-zoster virus, showed particularly striking results: it was associated with a 20% reduced probability of new dementia diagnosis over 7 years. These are not small benefits.

For an older adult, a 20% reduction in dementia risk approaches the magnitude of benefit seen from some other interventions touted for cognitive preservation. The reasons behind these protective effects likely involve preventing the very neuroinflammatory cascades described earlier. By preventing the initial infection or its reactivation, vaccination stops the immune system from being chronically activated against that particular pathogen. While vaccines do not prevent all pathogens and do not eliminate dementia risk, they represent one of the most evidence-supported interventions for reducing infection-driven cognitive decline. Updated vaccine recommendations for older adults—including influenza, pneumococcal, and zoster vaccines—should be viewed not just as protection against infection-related hospitalization, but as a strategy for preserving brain function in the second half of life.

Conclusion

Untreated pathogens contribute to earlier brain function decline through multiple mechanisms: chronic activation of brain immune cells, aggregation of proteins associated with Alzheimer’s disease, disruption of the blood-brain barrier, and systemic inflammation that penetrates the brain. The evidence shows that a person’s cumulative burden of infections over a lifetime, rather than a single catastrophic infection, is the primary driver of infection-related cognitive decline. The 50% increased dementia risk within 5 years of infection, coupled with the finding that infections often occur 5-6 years before formal diagnosis, underscores the silent nature of this threat.

By the time cognitive symptoms become obvious, significant brain damage has already occurred. Taking action now—treating infections promptly, maintaining vaccinations, supporting gut health, and reducing cumulative pathogen burden—offers tangible protection for the brain. Speak with a healthcare provider about which vaccines are appropriate for your age and health status, follow through with antibiotic treatment when infections occur, and remain vigilant about oral hygiene and other measures that reduce infection risk. The brain aging you prevent today through infection management is not a distant abstraction; it is the clarity of mind and memory you will preserve in the years ahead.